Analyst Ratings for Edgewise Therapeutics (EWTX)
EWTX Rating Summary
EWTX Price Target Summary
- Highest: $66.00 (Raymond James)
- Lowest: $25.00 (Stifel)
- Average: $50.38
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$50.38 (+35.5%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 83%
Avg. $ Target:
$50.38 (+35.5%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 83%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/16/2026 | William Blair | N/A | New Coverage | Outperform (N/A) |
N/A (N/A) |
37.02 (37.19) |
0.46% | Details |
| 7/9/2026 | Oppenheimer | Mazahir Alimohamed | New Coverage | Outperform (N/A) |
51.00 (N/A) |
46.30 (37.19) |
-19.68% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
